| 英文名称 | 中文名称 | CAS | MF |
|
1,3-Dioxolan-4-one,2,2-dimethyl-5-(1-methylethyl)-,(5R)-(9CI)
|
|
573987-84-5
|
C8H14O3
|
|
Piperidine, 2-ethyl-1-[1-oxo-3-(2-thienyl)-2-propenyl]- (9CI)
|
|
573992-93-5
|
C14H19NOS
|
|
2-cyano-N-(4-{[(2,6-dimethylpyrimidin-4-yl)amino]sulfonyl}phenyl)acetamide
|
2-氰基-N-[4-[(2,6-二甲基嘧啶-4-基)氨基磺酰基]苯基]乙酰胺
|
573993-14-3
|
C15H15N5O3S
|
|
Piperidine, 2,6-dimethyl-1-[1-oxo-3-(2-thienyl)-2-propenyl]- (9CI)
|
|
573993-62-1
|
C14H19NOS
|
|
2-Furancarboxamide,N-ethyl-5-methyl-(9CI)
|
N-乙基-5-甲基呋喃-2-甲酰胺
|
573993-77-8
|
C8H11NO2
|
|
4-[(3-Chloropropanoyl)amino]benzamide
|
4-[(3-氯-1-氧代丙基)氨基]苯甲酰胺
|
573994-42-0
|
C10H11ClN2O2
|
|
3-Chloro-N-cyclopropylpropanamide
|
3-氯-N-环丙基丙酰胺
|
573994-60-2
|
C6H10ClNO
|
|
Benzamide, 4-(1-methylethyl)-N-(3-methyl-2-pyridinyl)- (9CI)
|
|
573995-45-6
|
C16H18N2O
|
|
2-Butenoicacid,4-(3-methyl-1-piperidinyl)-4-oxo-(9CI)
|
|
573995-52-5
|
C10H15NO3
|
|
2-Furancarboxamide,N-(4,6-dimethyl-2-pyridinyl)tetrahydro-(9CI)
|
|
573997-83-8
|
C12H16N2O2
|
|
CHEMBRDG-BB 5697754
|
3-氯-N-(3-乙基苯基)丙酰胺
|
573997-99-6
|
C11H14ClNO
|
|
1-Pyrrolidinecarboximidamide,2-hydroxy-
|
|
574001-64-2
|
C5H11N3O
|
|
1H-[1,3]Diazepino[1,2-a][1,3]diazepine(9CI)
|
|
574003-48-8
|
C9H9N3
|
|
1H-Imidazo[4,5:4,5]thieno[2,3-d]pyrimidine (9CI)
|
|
574003-49-9
|
C7H4N4S
|
|
Spiro[cyclopropane-1,6(1H)-[3H]cyclopropa[3,4]pyrrolo[1,2-c]oxazole] (9CI)
|
|
574003-55-7
|
C9H9NO
|
|
Pyrimido[5,4-f][1,4]oxazepine (9CI)
|
|
574003-58-0
|
C7H5N3O
|
|
5-Isoxazolecarboxylicacid,3-(carboxymethoxy)-(9CI)
|
|
574005-34-8
|
C6H5NO6
|
|
1-Piperazinecarboxylic acid, 2,6-diMethyl-, 1,1-diMethylethyl ester, (2R,6R)-
|
(2R,6R)-2,6-二甲基-1-哌嗪羧酸叔丁酯
|
574007-62-8
|
C11H22N2O2
|
|
1-Piperazinecarboxylic acid, 2,6-diMethyl-, 1,1-diMethylethyl ester, (2S,6S)-
|
(2S,6S)-2,6-二甲基哌嗪-1-羧酸叔丁酯
|
574007-66-2
|
C11H22N2O2
|
|
Piperidine, 2-methyl-1-(4-pyridinylcarbonyl)- (9CI)
|
|
574008-50-7
|
C12H16N2O
|
|
Cyclopropanecarboxamide, N-(4-ethoxy-2-nitrophenyl)- (9CI)
|
|
574008-54-1
|
C12H14N2O4
|
|
4-(4-(Trifluoromethyl)phenyl)piperidine hydrochloride
|
4-(4-三氟甲基苯基)哌啶盐酸盐
|
574008-73-4
|
C12H15ClF3N
|
|
Piperidine, 1-(cyclopentylcarbonyl)-3,5-dimethyl- (9CI)
|
Cyclopentyl(3,5-dimethyl-1-piperidinyl)methanone
|
574008-98-3
|
C13H23NO
|
|
2-Furancarboxamide,5-methyl-N-(4-nitrophenyl)-(9CI)
|
|
574009-83-9
|
C12H10N2O4
|
|
Benzamide, 3-methyl-4-nitro-N-1H-tetrazol-5-yl- (9CI)
|
|
574010-14-3
|
C9H8N6O3
|
|
N-(1-Oxoheptyl)glycine Ethyl Ester
|
N-(1-Oxoheptyl)glycine Ethyl Ester
|
574010-47-2
|
C11H21NO3
|
|
3-Chloro-N-(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thien-2-yl)propanamide
|
3-氯-N-{3-氰基-4H,5H,6H,7H,8H-环庚[B]噻吩-2-基}丙酰胺
|
574010-55-2
|
C13H15ClN2OS
|
|
3-Pyridinecarboxamide,N-(3-ethylphenyl)-(9CI)
|
|
574010-87-0
|
C14H14N2O
|
|
Fexaramine
|
FEXARAMINE
|
574013-66-4
|
C32H36N2O3
|
|
(E)-methyl 3-(3-(N-(4-(benzo[d][1,3]dioxol-5-yl)benzyl)cyclohexanecarboxamido)phenyl)acrylate
|
FEXARINE
|
574013-67-5
|
C31H31NO5
|
|
(E)-methyl 3-(3-(N-(4-styrylbenzyl)cyclohexanecarboxamido)phenyl)acrylate
|
FEXARENE
|
574013-68-6
|
C32H33NO3
|
|
Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1,4,5,6,7,8-hexahydro-1-(3-methylphenyl)- (9CI)
|
|
574701-15-8
|
C22H21N3O
|
|
Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1-(2,5-dimethylphenyl)-1,4,5,6,7,8-hexahydro- (9CI)
|
|
574702-55-9
|
C23H23N3O
|
|
5-Indolizinemethanol,5,6,7,8-tetrahydro-,(5S)-(9CI)
|
|
574705-55-8
|
C9H13NO
|
|
Pitavastatin Sodium
|
匹伐他汀钠
|
574705-92-3
|
C25H23FNNaO4
|
|
4-chloro-2-phenyl-6-piperidinopyrimidine
|
4-氯-2-苯基-6-哌啶基嘧啶
|
574708-35-3
|
C15H16ClN3
|
|
3,5-Pyridinedicarboxylicacid,1,2-dihydro-6-methyl-2-oxo-,5-methylester,3-hydrazide(9CI)
|
|
574710-45-5
|
C9H11N3O4
|
|
Benzamide, 3,4-dichloro-N-1H-tetrazol-5-yl- (9CI)
|
|
574712-29-1
|
C8H5Cl2N5O
|
|
N-(2-chloropyridin-3-yl)trifluoroacetamide
|
|
574714-02-6
|
C7H4ClF3N2O
|
|
Piperidine, 1-(cyclopentylcarbonyl)-2-ethyl- (9CI)
|
Cyclopentyl(2-ethyl-1-piperidinyl)methanone
|
574718-40-4
|
C13H23NO
|
|
Benzamide, N-cyclooctyl-3-fluoro- (9CI)
|
|
574718-85-7
|
C15H20FNO
|
|
1-Naphthalenecarboxamide,N-1,3,4-thiadiazol-2-yl-(9CI)
|
|
574718-94-8
|
C13H9N3OS
|
|
Cyclopentanecarboxamide, N-(2,5-dichlorophenyl)- (9CI)
|
N-(2,5-Dichlorophenyl)cyclopentanecarboxamide
|
574718-99-3
|
C12H13Cl2NO
|
|
Ethyl (tetrahydro-furan-2-carbonyl)-amino-acetate
|
ETHYL (TETRAHYDRO-FURAN-2-CARBONYL)-AMINO-ACETATE
|
574719-90-7
|
C9H15NO4
|
|
Hydrazinecarboxylic acid, (1-propyl-4-piperidinylidene)-, methyl ester (9CI)
|
|
574720-10-8
|
C10H19N3O2
|
|
Propanamide, N-(3-ethylphenyl)-2,2-dimethyl- (9CI)
|
|
574720-81-3
|
C13H19NO
|
|
3-Cyclohexene-1-carboxylicacid,6-[[(3-methyl-2-pyridinyl)amino]carbonyl]-
|
|
574722-92-2
|
C14H16N2O3
|
|
Butanamide, 2-ethyl-N-(3-ethylphenyl)- (9CI)
|
|
574723-17-4
|
C14H21NO
|
|
Piperidine, 1-(cyclopropylcarbonyl)-4-(phenylmethyl)- (9CI)
|
|
574723-94-7
|
C16H21NO
|
|
Benzeneacetamide, α-(2-aminoethyl)-N-1H-indazol-5-yl-
|
苯乙酰胺, α-(2-氨基乙基)-N-1H-吲唑-5-基-
|
574726-31-1
|
C17H18N4O
|
|
tert-Butyl 3-amino-5-nitro-1H-indazole-1-carboxylate
|
3-亚氨基-5-硝基-2,3-二氢-1H-吲唑-1-羧酸叔丁酯
|
574729-25-2
|
C12H14N4O4
|
|
tert-butyl 3,5-diamino-1H-indazole-1-carboxylate
|
3,5-二氨基-1H-吲唑-1-羧酸叔丁酯
|
574729-26-3
|
C12H16N4O2
|
|
3-tert-Butoxycarbonylamino-2-(3,4-dichloro-phenyl)-propionic acid
|
3-(Boc-氨基)-2-(3,4-二氯苯基)丙酸
|
574729-44-5
|
C14H17Cl2NO4
|
|
Benzenemethanamine, 4-fluoro-N,alpha-dimethyl- (9CI)
|
1-(4-氟苯基)乙基](甲基)胺
|
574731-02-5
|
C9H12FN
|
|
(RS)-N-[1-(2-Fluorophenyl)propyl]methylamine, 98% min.
|
|
574731-04-7
|
C10H14FN
|
|
N-Methyl-1-[4-(trifluoromethyl)phenyl]ethylamine
|
N-甲基-1-(4-(三氟甲基)苯基)乙胺
|
574731-05-8
|
C10H12F3N
|
|
Methyl((1-[4-(trifluoromethoxy)phenyl]ethyl))amine
|
|
574731-10-5
|
C10H12F3NO
|
|
C2 Adamantanyl Galactosylceramide (d18:1/2:0)
|
半乳糖(Β) 金刚烷酰 神经酰胺
|
574738-16-2
|
C36H63NO8
|
|
Maihuatini Impurity 1
|
达克替尼杂质
|
574738-64-0
|
C8H5N3O4
|
|
Benzoic acid, 2-amino-4-hydroxy-5-nitro- (9CI)
|
|
574738-65-1
|
C7H6N2O5
|
|
2-Amino-4,5-bis-(2-methoxy-ethoxy)-benzoic acid >98%
|
厄洛替尼杂质29
|
574738-66-2
|
C13H19NO6
|
|
4(3H)-Quinazolinone, 6-(3-chloropropoxy)-7-Methoxy-
|
6-(3-氯丙氧基)-7-甲氧基-4(1H)-喹唑啉酮
|
574738-93-5
|
C12H13ClN2O3
|
|
Fmoc-MEPHG-OH
|
FMOC-N-METHYL-L-PHENYLGLYCINE
|
574739-36-9
|
C24H21NO4
|
|
2-(1-Amino-2-methylpropyl)aniline
|
574739-92-7
|
574739-92-7
|
C10H16N2
|
|
5-Hydroxymethyl-1,2-dihydro-pyrrolo[3,2,1-ij]quinolin-4-one
|
5-HYDROXYMETHYL-1,2-DIHYDRO-PYRROLO[3,2,1-IJ]QUINOLIN-4-ONE
|
574740-70-8
|
C12H11NO2
|
|
Acetamide, N-[(4-methoxyphenyl)methylene]-, [N(E)]- (9CI)
|
|
574743-55-8
|
C10H11NO2
|
|
Acetamide, N-[(4-methoxyphenyl)methylene]-, [N(Z)]- (9CI)
|
|
574743-56-9
|
C10H11NO2
|
|
(S)-(-)-1-(4-METHOXYPHENYL)ETHYLAMINE-HCl
|
S-4-甲氧基苯乙胺盐酸盐
|
574744-39-1
|
C9H14ClNO
|
|
7-(Benzyloxy)-4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinazoline
|
7-(BENZYLOXY)-4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINAZOLINE
|
574745-75-8
|
C25H20FN3O3
|
|
4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinazolin-7-ol
|
4-(4-氟-2-甲基-1H-吲哚-5-基氧基)-6-甲氧基喹唑啉-7-醇
|
574745-76-9
|
C18H14FN3O3
|
|
1-Piperazinepropanol,4-(2-fluoroethyl)-(9CI)
|
|
574745-95-2
|
C9H19FN2O
|
|
6-Quinazolinol, 4-chloro-7-methoxy-
|
4-氯-7-甲氧基喹唑啉-6-醇
|
574745-97-4
|
C9H7ClN2O2
|
|
1-Piperazineethanol,4-(2-fluoroethyl)-(9CI)
|
|
574746-09-1
|
C8H17FN2O
|
|
1-Piperazinepropanol,4-(2-propynyl)-(9CI)
|
|
574746-11-5
|
C10H18N2O
|
|
3,10-Difluoro-5,12-dimethyl-5,12-dihydroquino2,3-bacridine-7,14-dione
|
|
574749-25-0
|
C22H14F2N2O2
|
|
(2R,3S,4S)-2-[3,4-Bis(phenylMethoxy)phenyl]-3,4-dihydro-3,5,7-tris(phenylMethoxy)-2H-1-benzopyran-4-ol
|
(2R,3S,4S)-2-[3,4-Bis(phenylMethoxy)phenyl]-3,4-dihydro-3,5,7-tris(phenylMethoxy)-2H-1-benzopyran-4-ol
|
574749-29-4
|
C50H44O7
|
|
Ethanone, 1-[4,5-dihydro-2-(methylamino)-3-furanyl]-2,2,2-trifluoro- (9CI)
|
|
574749-64-7
|
C7H8F3NO2
|
|
alpha-L-Idopyranuronic acid, 1-deoxy-1-fluoro-5-C-fluoro- (9CI)
|
|
574752-49-1
|
C6H8F2O6
|
|
Pitavastatin Acyl Glucuronide
|
PITAVASTATIN ACYL GLUCURONIDE
|
574752-66-2
|
C31H32FNO10
|
|
1-Azabicyclo[3.2.1]octane,5,6-dimethyl-(9CI)
|
|
574754-53-3
|
C9H17N
|
|
1-Azabicyclo[4.2.1]nonane,6,7-dimethyl-(9CI)
|
|
574754-62-4
|
C10H19N
|
|
2-(4-propylphenyl)-5,5-dimethyl[1,3,2]dioxaborinane
|
2-(4-propylphenyl)-5,5-dimethyl[1,3,2]dioxaborinane
|
574755-16-1
|
C14H21BO2
|
|
7-(1H)Indazole sulfonic acid
|
1H-吲唑-7-磺酸
|
574758-47-7
|
C7H6N2O3S
|
|
1H-Indazole-5-carboxylic acid, 6-hydroxy-
|
6-羟基吲唑-5-羧酸
|
574758-53-5
|
C8H6N2O3
|
|
2-Pyrimidinamine, 4-(3-chlorophenyl)-N-[4-(trifluoromethyl)phenyl]-
|
2-PYRIMIDINAMINE, 4-(3-CHLOROPHENYL)-N-[4-(TRIFLUOROMETHYL)PHENYL]-
|
574759-62-9
|
C17H11ClF3N3
|
|
2,5-Pyrrolidinedione,1-ethyl-3-(tetrahydro-5-methyl-2-furanyl)-(9CI)
|
|
575114-75-9
|
C11H17NO3
|
|
2,5-Hexanedione,3-(5-ethyltetrahydro-2-furanyl)-(9CI)
|
|
575114-94-2
|
C12H20O3
|
|
2,5-Pyrrolidinedione,3-(5-ethyltetrahydro-2-furanyl)-1-methyl-(9CI)
|
|
575115-02-5
|
C11H17NO3
|
|
2,5-Pyrrolidinedione,1-ethyl-3-(5-ethyltetrahydro-2-furanyl)-(9CI)
|
|
575115-08-1
|
C12H19NO3
|
|
6H-Dicyclopent[c,d]isoxazole,1,2,3,3a,7,8-hexahydro-(9CI)
|
|
575342-65-3
|
C9H13NO
|
|
Spiro[4.4]nonan-1-ol, 6-amino-, (1R,5R,6R)-rel- (9CI)
|
|
575342-75-5
|
C9H17NO
|
|
Spiro[4.4]nonan-1-ol, 6-amino-, (1R,5R,6R)- (9CI)
|
|
575342-84-6
|
C9H17NO
|
|
Spiro[4.4]nonan-1-ol, 6-amino-, (1S,5S,6S)- (9CI)
|
|
575342-92-6
|
C9H17NO
|
|
Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1,4,5,6,7,8-hexahydro-1-(4-iodophenyl)- (9CI)
|
|
575430-40-9
|
C21H18IN3O
|
|
Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1,4,5,6,7,8-hexahydro-1-[3-(trifluoromethyl)phenyl]- (9CI)
|
|
575431-40-2
|
C22H18F3N3O
|
|
2-Propynenitrile,3-(3,5-difluorophenyl)-(9CI)
|
|
575433-44-2
|
C9H3F2N
|
|
1-(3,5-Difluorophenyl)propan-1-ol
|
|
575433-45-3
|
C9H10F2O
|
|
Pyridine-2,6-dicarboxylic acid mono-tert-butyl ester
|
6-叔丁氧基羰基吡啶甲酸
|
575433-76-0
|
C11H13NO4
|
|
2-Pyridinecarboxylic acid, 6-Methyl-, 1,1-diMethylethyl ester
|
6-甲基吡啶-2-羧酸叔丁酯
|
575433-87-3
|
C11H15NO2
|
|
Pyrrolidine, 1-(3-phenyl-1-thioxopropyl)- (9CI)
|
|
575446-88-7
|
C13H17NS
|